1. Home
  2. CYTK vs AYI Comparison

CYTK vs AYI Comparison

Compare CYTK & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$69.87

Market Cap

10.7B

Sector

Health Care

ML Signal

N/A

Logo Acuity Brands Inc.

AYI

Acuity Brands Inc.

N/A

Current Price

$301.23

Market Cap

9.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
AYI
Founded
1997
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
9.6B
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
CYTK
AYI
Price
$69.87
$301.23
Analyst Decision
Strong Buy
Buy
Analyst Count
19
6
Target Price
$89.26
$369.17
AVG Volume (30 Days)
1.7M
179.3K
Earning Date
05-05-2026
04-02-2026
Dividend Yield
N/A
0.28%
EPS Growth
N/A
N/A
EPS
N/A
11.45
Revenue
$13,368,000.00
$3,461,000,000.00
Revenue This Year
$7.37
$7.51
Revenue Next Year
$310.19
$5.14
P/E Ratio
N/A
$26.19
Revenue Growth
N/A
4.05
52 Week Low
$47.22
$257.04
52 Week High
$88.31
$380.17

Technical Indicators

Market Signals
Indicator
CYTK
AYI
Relative Strength Index (RSI) 35.17 28.50
Support Level $59.10 $281.33
Resistance Level $70.69 $300.73
Average True Range (ATR) 2.61 8.21
MACD -0.19 -3.54
Stochastic Oscillator 6.71 4.71

Price Performance

Historical Comparison
CYTK
AYI

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

Share on Social Networks: